- Home
- DJCO vs PSNL Comparison
DJCO vs PSNL Comparison
Compare DJCO & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DJCO | PSNL |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.2M | 729.1M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DJCO | PSNL |
|---|---|---|
| Price | $490.44 | $6.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 90.5K | ★ 1.3M |
| Earning Date | 02-17-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.50 | 33.58 |
| EPS | N/A | ★ N/A |
| Revenue | $41,384,000.00 | ★ $69,648,000.00 |
| Revenue This Year | N/A | $16.94 |
| Revenue Next Year | N/A | $36.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $348.63 | $2.83 |
| 52 Week High | $674.75 | $11.50 |
Technical Indicators
Market Signals| Indicator | DJCO | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 38.24 |
| Support Level | $481.78 | $4.31 |
| Resistance Level | $495.51 | $9.64 |
| Average True Range (ATR) | 34.45 | 0.66 |
| MACD | -1.94 | -0.15 |
| Stochastic Oscillator | 32.01 | 13.82 |
Price Performance
Historical ComparisonAbout DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.